Offering a potential antidote to health-care silos that can hamper and delay care, the Enterprise Imaging and Informatics Suite may revamp image sharing and communication between providers.
Offering the promise of secure image sharing, improved workflow efficiencies and enhanced integration with electronic health records (EHRs) and referring provider portals, a new software suite may provide radiologists with an emerging option for medical image management.
Seeking to develop an integrated hub with centralized patient data, Intelerad Medical Systems has launched the Enterprise Imaging and Informatics Suite at the 2022 Healthcare Information and Management Systems Society (HIMSS) Global Health Conference and Exhibition in Orlando, Fla.
Incorporating components from acquired brands ranging from Ambra Health to HeartIT, the Enterprise Imaging and Informatics Suite reportedly facilitates improved interoperability, greater efficiency, and improved communication between providers, according to Intelerad.
“Intelerad’s Enterprise Imaging and Informatics Suite provides hospitals and health systems with an industry-leading enterprise imaging solution,” noted Mike Lipps, the chief executive office for Intelerad. “As demand for managing, sharing and analyzing patient data and images continues to grow, health-care customers need a powerful, scalable, vendor-neutral imaging system that improves overall performance.”
Intelerad says key components of the software suite, among others, include:
• the Clario SmartWorklist™, which enables radiologists to efficiently manage imaging and patient data in one place;
• Ambra Image Exchange, which enhances collaboration between providers through secure transmission of patent images; and
• the Cardiovascular Suite, which features registry alignment, analytics reports and EHR integration.
Prostate MRI Study Examines Key Predictors of False-Negative and False-Positive Results
February 17th 2025Researchers found that patients with high PSA density have more than double the risk of false-negative findings on prostate MRI and those with low PSA density are significantly less likely to have false-positive results.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.